Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
KNTE | Kinnate Biopharma Inc. | Meltz Mark A | COO General Counsel Secretary | Dec 01, 2023 | Option Exercise | $2.25 | 541 | 1,217 | 28,136 | Dec 05, 2023, 05:00 PM | |
KNTE | Kinnate Biopharma Inc. | Meltz Mark A | COO General Counsel Secretary | Sep 01, 2023 | Option Exercise | $2.35 | 541 | 1,271 | 28,677 | Sep 06, 2023, 05:00 PM | |
KNTE | Kinnate Biopharma Inc. | Meltz Mark A | COO General Counsel Secretary | Jun 01, 2023 | Option Exercise | $4.30 | 541 | 2,326 | 29,218 | Jun 05, 2023, 05:00 PM | |
KNTE | Kinnate Biopharma Inc. | Meltz Mark A | COO General Counsel Secretary | Mar 01, 2023 | Option Exercise | $5.21 | 638 | 3,324 | 27,286 | Mar 03, 2023, 05:57 PM | |
KNTE | Kinnate Biopharma Inc. | Meltz Mark A | COO General Counsel Secretary | Dec 01, 2022 | Option Exercise | $7.75 | 541 | 4,193 | 27,924 | Dec 02, 2022, 08:00 PM | |
BOLD | Audentes Therapeutics, Inc. | Meltz Mark A | SVP, General Counsel | Jan 15, 2020 | Option Exercise | $60.00 | 32,705 | 1,962,300 | 0 | Jan 15, 2020, 01:32 PM | |
BOLD | Audentes Therapeutics, Inc. | Meltz Mark A | SVP, General Counsel | Dec 12, 2019 | Option Exercise | $59.37 | 4,628 | 274,764 | 32,705 | Dec 16, 2019, 06:04 PM |